IPP Bureau
USFDA accepts dupilumab for priority review in adults with prurigo nodularis
By IPP Bureau - June 01, 2022
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
FDA approves Roche’s Evrysdi for use in babies under two months with SMA
By IPP Bureau - June 01, 2022
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Tetra Bio-Pharma appoints CFO
By IPP Bureau - June 01, 2022
Auld is a seasoned Financial Executive with over 30 years of relevant experience
US FDA accepts new drug application filed by Avillion for AstraZeneca's PT027
By IPP Bureau - June 01, 2022
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
Jubilant HollisterStier enters into agreement of $149.6 mn with US Govt to expand critical vaccine manufacturing capacity
By IPP Bureau - June 01, 2022
This agreement is in addition to the $92 million filling line expansion announced in November 2021
NATCO launches first generic version of Nexavar Tablets in the US
By IPP Bureau - June 01, 2022
The product will be launched by NATCO's commercial partner Viatris.
Thyrocare unveils new brand identity
By IPP Bureau - June 01, 2022
New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services
Novavax initiates phase 3 trial of its COVID-19 omicron booster
By IPP Bureau - June 01, 2022
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Glenmark Pharma reports revenue growth of 5.6% YoY in Q4
By IPP Bureau - May 30, 2022
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
LintonPharm to release data on Catumaxomab at ASCO meeting
By IPP Bureau - May 30, 2022
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
Strides receives USFDA approval for Ibuprofen Oral Suspension
By IPP Bureau - May 30, 2022
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
Granules India chooses Veeam to protect digital business
By IPP Bureau - May 30, 2022
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
OS-SiA digital pathology scanner developed by OptraSCAN granted US patent
By IPP Bureau - May 30, 2022
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
Blockchain improves product authenticity in supply chain, finds GlobalData
By IPP Bureau - May 30, 2022
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors
